An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
May 23rd, 2018
19.1K views
Single-cell sequencing reveals genotypic heterogeneity in biological systems, but current technologies lack the throughput necessary for the deep profiling of community composition and function. Here, we describe a microfluidic workflow for sequencing >50,000 single-cell genomes from diverse cell populations.
Overview
This study presents a microfluidic workflow for sequencing over 50,000 single-cell genomes, addressing the limitations of current technologies in profiling community composition and function. The method preserves genomic heterogeneity by encapsulating and barcoding cells individually.
Key Study Components
Area of Science
- Single-cell genomics
- Microfluidics
- Genomic sequencing
Background
- Single-cell sequencing reveals genotypic heterogeneity.
- Current technologies lack throughput for deep profiling.
- Microfluidics can enhance sequencing capabilities.
- Preserving genomic heterogeneity is crucial for accurate analysis.
Purpose of Study
- To develop a high-throughput method for single-cell sequencing.
- To demonstrate the adaptability of the workflow for various cell types.
- To encapsulate and barcode cells while maintaining genomic integrity.
Methods Used
- Preparation of agarose and cell suspension for microfluidic devices.
- Encapsulation and lysis of individual cells in microgels.
- Barcoding of genomic DNA using tagmentation.
- Thermal cycling for DNA recovery from emulsions.
Main Results
- Successfully sequenced genomes from tens of thousands of single cells.
- Demonstrated high throughput and efficiency of the microfluidic workflow.
- Verified encapsulation of cells in microgels under microscopy.
- Adaptability of the method for different cell types was confirmed.
Conclusions
- The microfluidic workflow significantly enhances single-cell sequencing capabilities.
- This method preserves genomic heterogeneity, crucial for accurate profiling.
- Future applications can extend beyond microbes to various cell types.
Frequently Asked Questions
What is the main advantage of this microfluidic workflow?
The main advantage is its high throughput, allowing for sequencing of tens of thousands of single cells.
Can this method be used for cell types other than microbes?
Yes, the workflow can be adapted for different cell types with minor modifications.
How does this method preserve genomic heterogeneity?
By encapsulating and barcoding cells individually, it avoids the loss of heterogeneity seen in conventional methods.
What are the key steps in the protocol?
Key steps include preparing agarose, encapsulating cells, barcoding DNA, and thermal cycling for recovery.
What is the significance of sequencing over 50,000 single-cell genomes?
It allows for a comprehensive understanding of community composition and function in biological systems.
What equipment is needed for this workflow?
The workflow requires microfluidic devices, syringes, and a thermal cycler among other laboratory equipment.
Executive Industry Relevance
Single-cell genome sequencing enables deconvolution of heterogeneous populations, a critical capability for target validation in complex disease models. The SiC-seq platform achieves ultrahigh throughput (>50,000 cells per run) while preserving genomic integrity, directly supporting scalable discovery workflows. This positions the method as a predictive de-risking tool for early target identification in microbial and mammalian systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by resolving genomic heterogeneity in mixed populations.
- Operational Value: Supports functional target validation through barcoded single-cell resolution of genotype-phenotype links.
- Predictive Value: Reduces mechanistic ambiguity by providing unbiased, low-bias genomic readouts across thousands of cells.
Screening & Assay Development
- Assay Readiness: Generates standardized, barcode-demultiplexed sequencing outputs suitable for quantitative screening campaigns.
- Scalability: Microfluidic merger enables pairing of genomes with unique oligonucleotides, supporting reproducible, high-density library preparation.
- Platform Reuse: Adaptable workflow accommodates different cell types via device dimension modifications, enhancing cross-project utility.
Translational & Preclinical Research
- Translational Continuity: Uniform coverage and low dropout rates (verified via frequency distribution of normalized coverage) support reliable extrapolation from discovery to preclinical models.
- Disease-Relevant Systems: Applicable to diverse cell populations, including synthetic communities, enabling modeling of complex microbiomes or tissue niches.
- Risk-Adjusted Advancement: High-throughput data empowers statistical confidence in target prevalence and heterogeneity, informing go/no-go decisions.
Pipeline & Workflow Integration
The SiC-seq method integrates into the discovery continuum from hypothesis testing through lead identification, particularly for targets requiring single-cell resolution. It enables scalable preparation of validated biological systems for downstream analytics and screening.
- Discovery Biology: Supports pathway clarification and biological de-risking by isolating and barcoding individual cell genomes.
- Screening: Delivers assay-ready, quantitative sequencing data with defined thresholds (e.g., >7.5 kbp/group) to filter artifacts.
- Analytics: Generates demultiplexed read groups and coverage metrics (e.g., 5.55X average) enabling comparative condition analysis.
- Translational Research: Uniform coverage and adaptability to various cell types support biomarker-aligned preclinical continuity.
- Enterprise Reuse: Microfluidic platform design allows standardization across projects, reducing revalidation burden.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through high-throughput, low-bias single-cell genomic profiling.
- Operational Value: Standardization via microfluidic encapsulation, barcoding, and thermal cycling steps.
- Strategic Value: Improved go/no-go decisions via statistically robust sampling of cellular heterogeneity.
- Portfolio Impact: Risk-adjusted prioritization enabled by comprehensive single-cell genome sequencing of large populations.
Implementation Considerations
- Requires expertise in microfluidic device operation, syringe pump calibration, and fluorescence microscopy for encapsulation verification.
- Dependent on specialized reagents: low-melting agarose, density gradient media, fluorinated oils (HFE, PFO, FC-40), surfactants (PFPE-PEG), and tagmentation mixes.
- Necessitates thermal cycling infrastructure and emulsion handling equipment (e.g., gel-loading tips, vortexers, centrifuges).
- Adaptation to mammalian or primary cells may require optimization of lysis, tagmentation, and encapsulation efficiency.
- Practical limitation: maintaining ~1 cell/barcode per 10 droplets to minimize doublets and preserve single-cell data integrity.
Biopharma FAQs
Why does single-cell resolution matter for target validation?
Single-cell resolution prevents averaging artifacts that obscure rare or subpopulations, enabling accurate assessment of target heterogeneity and prevalence in complex samples.
How does microfluidic encapsulation improve assay reproducibility?
Encapsulation in microgels compartmentalizes lysis and tagmentation, reducing well-to-well variability and enabling standardized processing of thousands of individual cells.
What quantitative outputs enable hit selection in screening campaigns?
Demultiplexed barcode groups and coverage uniformity metrics (e.g., average 5.55X coverage) provide quantitative thresholds to filter PCR artifacts and identify true single-cell signals.
Why are replication requirements critical for cross-functional collaboration?
Reproducible encapsulation rates and barcode recovery ensure consistent data generation across runs, allowing biology, assay development, and analytics teams to align on quality thresholds.
What statistical capabilities are needed before implementing this workflow?
Teams require ability to analyze barcode frequency distributions, coverage uniformity, and group size thresholds to validate data quality and distinguish biological signal from technical noise.
Chapters in this video
0:05
Title
0:48
Encapsulation of Cells in Agarose Microgels
2:48
Breaking the Agarose Microgels
3:54
Generating Barcode Droplets by Digital PCR
4:53
Tagmentation of Genomic DNA in Droplets
5:48
Single-cell Barcoding by Microfluidic Double Merger
8:25
Results: Ultrahigh Throughput Sequencing of Single-cell Genomes
9:24
Conclusion
